Chemokine receptor binding heterocyclic compounds with enhanced efficacy
申请人:Bridger J. Gary
公开号:US20050059702A1
公开(公告)日:2005-03-17
Compounds that interact with the CXCR4 receptor are described. These compounds are useful in treating, for Example, HIV infection and inflammatory conditions such as rheumatoid arthritis, as well as asthma or cancer, and are useful in methods to elevate progenitor and stem cell counts as well as methods to elevate white blood cell counts.
CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY
申请人:BRIDGER Gary J.
公开号:US20090281308A1
公开(公告)日:2009-11-12
Compounds that interact with the CXCR4 receptor are described. These compounds are useful in treating, for Example, HIV infection and inflammatory conditions such as rheumatoid arthritis, as well as asthma or cancer, and are useful in methods to elevate progenitor and stem cell counts as well as methods to elevate white blood cell counts.
Method of making a 2,6-diaryl piperidine derivative
申请人:Genzyme Corporation
公开号:EP2664617A1
公开(公告)日:2013-11-20
Methods for preparing 2,6-diaryl piperidine derivatives are described. More particularly, 2,6-diaryl piperidines having specific formulae are prepared by cyclocondensation of an aryl or heteroaryl aldehyde with 1,3-acetonedicarboxylic acid.